- Home
- CZR vs LNTH Comparison
CZR vs LNTH Comparison
Compare CZR & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CZR | LNTH |
|---|---|---|
| Founded | 1937 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.4B |
| IPO Year | 1989 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CZR | LNTH |
|---|---|---|
| Price | $23.51 | $67.30 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 6 |
| Target Price | $35.88 | ★ $77.33 |
| AVG Volume (30 Days) | ★ 8.3M | 1.0M |
| Earning Date | 10-28-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.39 |
| Revenue | ★ $11,369,000,000.00 | $1,525,933,000.00 |
| Revenue This Year | $3.09 | $0.01 |
| Revenue Next Year | $2.73 | $1.24 |
| P/E Ratio | ★ N/A | $27.84 |
| Revenue Growth | 0.87 | ★ 1.95 |
| 52 Week Low | $18.25 | $47.25 |
| 52 Week High | $40.00 | $111.29 |
Technical Indicators
Market Signals| Indicator | CZR | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 56.60 | 73.35 |
| Support Level | $22.95 | $60.15 |
| Resistance Level | $24.94 | $64.40 |
| Average True Range (ATR) | 0.81 | 2.01 |
| MACD | 0.18 | 0.77 |
| Stochastic Oscillator | 64.35 | 97.94 |
Price Performance
Historical ComparisonAbout CZR Caesars Entertainment Inc.
Caesars Entertainment includes about 50 domestic gaming properties across the Las Vegas (49% of 2024 EBITDAR before corporate expenses) and regional (46%) markets. Additionally, the company hosts managed properties and digital assets that produced marginal EBITDA in 2024. Caesars' US presence roughly doubled with the 2020 acquisition by Eldorado, which built its first casino in Reno, Nevada, in 1973 and expanded its presence through prior acquisitions to over 20 properties before merging with legacy Caesars. Caesars' brands include Caesars, Harrah's, Tropicana, Bally's, Isle, and Flamingo. Also, the company owns the US portion of William Hill (it sold the international operation in 2022), a digital sports betting platform.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.